J G Kenna

1.7k total citations
26 papers, 1.3k citations indexed

About

J G Kenna is a scholar working on Pharmacology, Hepatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J G Kenna has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Hepatology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J G Kenna's work include Liver physiology and pathology (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). J G Kenna is often cited by papers focused on Liver physiology and pathology (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). J G Kenna collaborates with scholars based in United Kingdom, United States and Switzerland. J G Kenna's co-authors include David D. Christ, L R Pohl, Hiroaki Satoh, Lance R. Pohl, Erik Eliasson, Jackie L. Martin, Hiroshi Satoh, Hiroko Satoh, J Neuberger and Brian M. Martin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Gut.

In The Last Decade

J G Kenna

26 papers receiving 1.3k citations

Peers

J G Kenna

PHARM

HEPAT

APM

ONCOL

L R Pohl United States

Jackie L. Martin United States

David D. Christ United States

Marina Tinel France

J. D. Tange Australia

Mohammed Bourdi United States

Philippe Coassolo Switzerland

Josef Gut Switzerland

C. Girre France

Sevasti B. Koukouritaki United States

L R Pohl United States

J G Kenna

747 ×1.2

PHARM

356 ×1.7

110 ×0.6

HEPAT

94 ×0.5

APM

218 ×1.3

ONCOL

Citations per year, relative to J G Kenna J G Kenna (= 1×) peers L R Pohl

Countries citing papers authored by J G Kenna

Since Specialization

Citations

This map shows the geographic impact of J G Kenna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J G Kenna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J G Kenna more than expected).

Fields of papers citing papers by J G Kenna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J G Kenna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J G Kenna. The network helps show where J G Kenna may publish in the future.

Co-authorship network of co-authors of J G Kenna

This figure shows the co-authorship network connecting the top 25 collaborators of J G Kenna. A scholar is included among the top collaborators of J G Kenna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J G Kenna. J G Kenna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dearman, Rebecca J., et al.. (2002). Immunogenic properties of rapidly digested food proteins following gavage exposure of mice: a comparison of ovalbumin with a potato acid phosphatase preparation. Food and Chemical Toxicology. 40(5). 625–633. 35 indexed citations

Eliasson, Erik & J G Kenna. (1996). Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.. Molecular Pharmacology. 50(3). 573–582. 128 indexed citations

Kitteringham, N.R., J G Kenna, & BK Park. (1995). Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane‐associated hepatitis.. British Journal of Clinical Pharmacology. 40(4). 379–386. 30 indexed citations

Kenna, J G, et al.. (1994). Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting.. Journal of Pharmacology and Experimental Therapeutics. 270(3). 1325–1333. 13 indexed citations

Christen, Urs, Janet Quinn, Stephen J. Yeaman, et al.. (1994). Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. European Journal of Biochemistry. 223(3). 1035–1047. 35 indexed citations

Pelt, Frank N.A.M. van & J G Kenna. (1994). Formation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro. Biochemical Pharmacology. 48(3). 461–471. 9 indexed citations

Smith, Gillian, et al.. (1993). Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis. The Lancet. 342(8877). 963–964. 35 indexed citations

Pumford, Neil R., Brian M. Martin, David G. Thomassen, et al.. (1993). Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72. Chemical Research in Toxicology. 6(5). 609–615. 38 indexed citations

Pelt, Frank N.A.M. van, et al.. (1993). Generation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro. Toxicology in Vitro. 7(4). 311–315. 7 indexed citations

10.

Kenna, J G, Jackie L. Martin, & Lance R. Pohl. (1992). The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane treated rats. Biochemical Pharmacology. 44(4). 621–629. 19 indexed citations

11.

Kitteringham, N.R., et al.. (1992). Conjugation of dinitrofluorobenzene to plasma proteins in vivo in the rat.. Drug Metabolism and Disposition. 20(5). 625–631. 5 indexed citations

12.

Gut, Josef, Urs Christen, Jörg Huwyler, Maria Bürgin, & J G Kenna. (1992). Molecular mimicry of trifluoroacetylated human liver protein adducts by consitutive proteins and immunochemical evidence for its impairment in halothane hepatitis. European Journal of Biochemistry. 210(2). 569–576. 22 indexed citations

13.

Martin, Jackie L., J G Kenna, & Lance R. Pohl. (1990). Antibody Assays for the Detection of Patients Sensitized to Halothane. Anesthesia & Analgesia. 70(2). 154???159–154???159. 63 indexed citations

14.

Kenna, J G, José Luis Fernández Martín, Hiroaki Satoh, & L R Pohl. (1990). Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane.. Drug Metabolism and Disposition. 18(5). 788–793. 60 indexed citations

15.

Pohl, Lance R., J G Kenna, Hiroko Satoh, David D. Christ, & Jackie L. Martin. (1989). Neoantigens Associated with Halothane Hepatitis. Drug Metabolism Reviews. 20(2-4). 203–217. 79 indexed citations

16.

Satoh, Hiroaki, et al.. (1989). Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.. Proceedings of the National Academy of Sciences. 86(1). 322–326. 102 indexed citations

17.

Pohl, L R, Hiroshi Satoh, David D. Christ, & J G Kenna. (1988). The Immunologic and Metabolic Basis of Drug Hypersensitivities. The Annual Review of Pharmacology and Toxicology. 28(1). 367–387. 143 indexed citations

18.

Kenna, J G, Hiroaki Satoh, David D. Christ, & L R Pohl. (1988). Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.. Journal of Pharmacology and Experimental Therapeutics. 245(3). 1103–1109. 170 indexed citations

19.

Christ, David D., et al.. (1988). Enflurane Metabolism Produces Covalently Bound Liver Adducts Recognized by Antibodies from Patients with Halothane Hepatitis. Anesthesiology. 69(6). 833–838. 92 indexed citations

20.

Kenna, J G, et al.. (1987). Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis.. Journal of Pharmacology and Experimental Therapeutics. 242(2). 733–740. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact